Pfizer Inc. (NYSE: PFE) today announced updated follow-up results from the single-arm Phase 2 PHAROS trial evaluating BRAFTOVI® (encorafenib ...

(UroToday.com) The 2025 European Society of Medical Oncology (ESMO) Annual Congress held in Berlin, Germany between September 17 th and 21 st was host to the session Mini oral session: GU tumours, ...

CStone Pharmaceuticals ("CStone," HKEX: 2616),  an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, autoimmune/inflammation, and other key ...

成年人的字典里，没有容易二字，除了长胖的肚子。中年胖肚子的原因，说来说去，无非是饭局多、压力大、坐得久、嘴巴馋……的老几样。还有没有点新鲜的？有！很多人不知道，睡觉时也有个问题，每天都在为你的肚子变大而不懈努力……01缺觉2个星期肚子胖一圈科学家做了 ...

An mRNA cancer vaccine carries its own immune booster and lights up when it starts working, showing treatment success in mice ...

Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice ...

Invikafusp alfa demonstrated significant antitumor activity in TMB-H and MSI-H tumors resistant to immune checkpoint blockade, with ORRs ranging from 20.5% to 33.3%. The trial's safety profile was ...

NX-1607 demonstrated on-target peripheral immune activation characteristic of an active immune-oncology agent with a novel immune checkpoint ...

Researchers have created human embryos by taking nuclei from ordinary skin cells, placing them into donated eggs, and ...

Avantor AVTR recently entered into a strategic partnership with BlueWhale Bio to accelerate innovation in CAR-T cell therapy ...

Discover AST SpaceMobile’s potential in space-based cellular broadband, market opportunities, and smart investing strategies.

(PFS) of 50% in the higher 15 mg/kg dose cohort compares favorably to historical PD-(L)1 refractory settings – All clinical responses, including a complete response, observed in the higher 15 mg/kg ...